Chinese expert consensus on immunotherapy for gynecological malignant tumors (2023 edition)

Chinese expert consensus on immunotherapy for gynecological malignant tumors (2023 edition)

Immunotherapy, as the fourth largest anti-tumor treatment method, has made breakthrough progress in the field of cancer treatment. Checkpoint inhibitors have been widely used in the treatment of various malignant tumors, and a lot of clinical evidence and experience have also been accumulated in the...

Full description

Bibliographic Details
Main Author:	Society of Onco-Endocrinology of Chinese Anti-Cancer Association
Format:	Article
Language:	English
Published:	Editorial Office of China Oncology 2023-10-01
Series:	Zhongguo aizheng zazhi
Subjects:	\|immunotherapy\|gynecological malignant tumors\|immune checkpoint inhibitors
Online Access:	http://www.china-oncology.com/fileup/1007-3639/PDF/1698723455992-12434734.pdf

Similar Items

Expert consensus on metformin adjuvant therapy in malignant tumor patients with diabetes mellitus type 2 (2022 edition)
by: Society of Onco-endocrinology of Chinese Anti-Cancer Association
Published: (2022-11-01)

Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors (2022 edition)
by: The Society of Gynecological Cancer of China Anti-Cancer Association
Published: (2022-08-01)

Expert consensus on genetic counseling in gynecological oncology (2023 edition)
Published: (2023-11-01)

Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
by: Locke D. Uppendahl, et al.
Published: (2018-01-01)

Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer
by: Chinese Society of Clinical Oncology, Expert Committee on Tumor Vascular-targeted Therapy, et al.
Published: (2021-11-01)

Chinese expert consensus on clinical application of recombinant oncolytic adenovirus in the treatment of malignant tumors
by: Expert Committee on Immunotherapy of Chinese Society of Clinical Oncology , Professional Committee on Cancer Biotherapy of Shanghai Anticancer Association
Published: (2023-05-01)

Clinical Practice Guidelines for Immune Checkpoint Inhibitor Therapy in Gynecological Tumors
by: Gynecological Oncology Society of Chinese Medical Association
Published: (2021-11-01)

Guidelines for the management of tumor-associated hyperglycemia (2021 edition)
by: Onco-endocrinology Society of Chinese Anti-Cancer Association, Onco-endocrinology Committee of Chongqing Association of Integrative Medicine
Published: (2021-07-01)

Chinese expert consensus on immunotherapy for advanced non-small cell lung cancer with oncogenic driver mutations (2023 edition)
by: The Society of Cancer Precision Medicine of Chinese Anti-Cancer Association; The Lung Cancer Expert Group of Chinese Medical Association Publishing House, et al.
Published: (2024-05-01)

Engineered T Cell Therapy for Gynecologic Malignancies: Challenges and Opportunities
by: Yifan Xu, et al.
Published: (2021-07-01)

Expert consensus on precision detection of intrahepatic cholangiocarcinoma (2024 edition)
by: Pathology Group, Chinese Society of Liver Cancer of Chinese Anti-Cancer Association; Liver Pathology Group, Chinese Society of Pathology of Chinese Anti-Cancer Association; Tumor Pathology Committee of Shanghai Anti-Cancer Association, Shanghai 200032, China
Published: (2025-02-01)

Application of the da Vinci robot in gynecologic malignancies: A bibliometric analysis (2005 – 2023)
by: Wenxiang Wang, et al.
Published: (2023-11-01)

Expert consensus on the clinical application of antibody‐drug conjugates in the treatment of malignant tumors (2021 edition)
by: Professional Committee on Clinical Research of Oncology Drugs, Chinese Anti‐Cancer Association, et al.
Published: (2022-06-01)

Modern approach to the management of genitourinary syndrome in women with gynecological malignancies
by: Kovacevic Nina, et al.
Published: (2023-07-01)

Recent Advances in Gynecological Malignancies: Focus on ASCO 2023
by: Olga Bodriagova, et al.
Published: (2023-09-01)

BUB1B and gynecological malignant tumors
by: HOU Yiying, WEI Fang
Published: (2024-12-01)

Expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition)
by: Committee of Breast Cancer Society, Chinese Anti-Cancer Association, Breast Surgeons Committee of Surgeons Branch, Chinese Medical Doctor Association, Committee of Breast Cancer Society, Shanghai Anti-Cancer Association
Published: (2022-09-01)

Sclerosing mesenteritis mimics gynecologic malignancy
by: Christina Tierney, et al.
Published: (2015-04-01)

Disparities in Gynecological Malignancies
by: Sudeshna eChatterjee, et al.
Published: (2016-02-01)

The Influence of Gynecological Malignancies and Patient Characteristics on Fall Risk Perception
by: Jingjing Gong, et al.
Published: (2024-05-01)

Potential role of radiation therapy in augmenting the activity of immunotherapy for gynecologic cancers
by: Son CH, et al.
Published: (2017-10-01)

EGFR-TKI ADR Management Chinese Expert Consensus
by: Chinese Society of Lung Cancer, Chinese Anti-Cancer Association
Published: (2019-02-01)

The Chinese Expert Consensus Recommendations on Molecular Testing in Endometrial Cancer (2021 edition)
by: The Society of Gynecological Cancer of China Anti-Cancer Association, Chinese Society of Pathology of the Chinese Medical Association, National Pathology Quality Control Center
Published: (2021-11-01)

Prevention of diseases in Gynecology
by: Sebija Izetbegovic, et al.
Published: (2013-01-01)

Current Update on PET/MRI in Gynecological Malignancies—A Review of the Literature
by: Mayur Virarkar, et al.
Published: (2023-01-01)

Application of organoids in drug screening of gynecological malignant tumors
by: JIANG Yuanyuan, WEI Wenfei, WU Jingya, LI Huawen
Published: (2024-11-01)

Molecular Signature of Gynecological Malignancies: A Narrative Review
by: Samah Saharti
Published: (2022-08-01)

Expert consensus on perioperative comprehensive treatment for high risk prostate cancer (2023 edition)
by: Society of Male Reproductive System Oncology, China Anti-Cancer Association
Published: (2023-12-01)

Progress of Artificial Intelligence in Gynecological Malignant Tumors
by: Zhou J, et al.
Published: (2020-12-01)

Advances in Immunotherapy for Malignant Pleural Mesothelioma
by: Yujia CHI, et al.
Published: (2022-04-01)

Uterine Clostridium perfringens infection related to gynecologic malignancy
by: Kevin M. Kremer, et al.
Published: (2017-11-01)

Editorial: The challenge of immunity evaluation and immunotherapy in gynecologic and urologic oncology
by: Ruirong Tan, et al.
Published: (2023-08-01)

Immunotherapy in genitourinary malignancies
by: Kathan Mehta, et al.
Published: (2017-04-01)

Intraoperative Flow Cytometry for the Characterization of Gynecological Malignancies
by: Zoi Anastasiadi, et al.
Published: (2022-09-01)

Improving clinical trial enrollment in minority racial and ethnic patients with gynecologic malignancy
by: Olivia D. Lara, et al.
Published: (2024-10-01)

Research Progress on Structure and Anti-Gynecological Malignant Tumor of Shikonin
by: Li-Na Ke, et al.
Published: (2022-07-01)

Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition)
by: Cancer Assessment Society of China Anti-Cancer Association, Cancer Pain Society of Fujian Anti-Cancer Association
Published: (2024-08-01)

Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version)
by: The Society of Cancer Multidisciplinary Diagnosis and Treatment, China Anti-Cancer Association, The Society of Cancer Endocrinology, China Anti-Cancer Association
Published: (2022-07-01)

Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)
by: Xiufeng Liu, et al.
Published: (2024-01-01)

Targeting WEE1 Kinase in Gynecological Malignancies
by: Zhang W, et al.
Published: (2024-06-01)